MILWAUKEE, Feb. 14 /PRNewswire-FirstCall/ — Merge Technologies Incorporated, d.b.a. Merge Healthcare (NASDAQ:MRGE) , announced today that it has filed with the Securities and Exchange Commission a final prospectus relating to its offering of Common Stock issuable in connection with its June 2005 merger with Cedara Software Corp. The Merge Common Shares can be issued in exchange for the exchangeable shares which were issued in 2005 by Merge Cedara ExchangeCo Limited (TSX: MRG), an indirect, wholly-owned subsidiary of Merge, to former Cedara stockholders in connection with the merger. The final prospectus is available at: http://www.sec.gov/Archives/edgar/data/944765/000110465907010211/a07- 4445_1424b3.htm .
Holders of the ExchangeCo exchangeable shares may effect the exchange in accordance with the procedures described in the final prospectus. Merge urges the holders of the exchangeable shares to carefully review the final prospectus.
A Post-Effective Amendment to the Company’s Registration Statement relating to these securities has been filed with the Securities and Exchange Commission and has become effective. This press release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of these securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. The offering was made solely by means of a prospectus.
Merge Healthcare is a market leader in the development and delivery of medical imaging and information management software and services. Our innovative software solutions use leading-edge imaging software technologies that accelerate market delivery for our OEM customers, while our end-user solutions improve our customers’ productivity and enhance the quality of patient care they provide. For additional information, visit our website at http://www.merge.com/ .